BR0308874A - Composição aquosa injetável, método para produzir a mesma, e, uso de copolìmeros em bloco polioxipropileno/polioxietileno - Google Patents

Composição aquosa injetável, método para produzir a mesma, e, uso de copolìmeros em bloco polioxipropileno/polioxietileno

Info

Publication number
BR0308874A
BR0308874A BR0308874-0A BR0308874A BR0308874A BR 0308874 A BR0308874 A BR 0308874A BR 0308874 A BR0308874 A BR 0308874A BR 0308874 A BR0308874 A BR 0308874A
Authority
BR
Brazil
Prior art keywords
aqueous composition
polyoxypropylene
injectable aqueous
block copolymers
producing same
Prior art date
Application number
BR0308874-0A
Other languages
English (en)
Other versions
BR0308874B1 (pt
Inventor
William Blakely
Lillian Cromie
Sean Duffy
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of BR0308874A publication Critical patent/BR0308874A/pt
Publication of BR0308874B1 publication Critical patent/BR0308874B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO AQUOSA INJETáVEL, MéTODO PARA PRODUZIR A MESMA E USO DE COPOLìMEROS EM BLOCO POLIOXIPROPILENO/POLIOXIETILENO". Uma composição aquosa injetável para uso veterinário contendo um composto antiinflamatório não esteroidal em um montante de cerca de 0,25 a 30 % (p/v) junto com um tensoativo polimérico oxigenado fisiologicamente aceitável em um montante de cerca de 0,5 a 20 % (p/v).
BRPI0308874-0A 2002-04-02 2003-03-31 Solução injetável estável em temperatura ambiente para uso veterinário, e método para produzir a mesma BR0308874B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0207529.9A GB0207529D0 (en) 2002-04-02 2002-04-02 Injectable veterinary composition for small animals
GB0207529.9 2002-04-02
PCT/GB2003/001404 WO2003082340A1 (en) 2002-04-02 2003-03-31 Injectable veterinary composition for small animals

Publications (2)

Publication Number Publication Date
BR0308874A true BR0308874A (pt) 2005-01-04
BR0308874B1 BR0308874B1 (pt) 2014-06-10

Family

ID=9934049

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0308874-0A BR0308874B1 (pt) 2002-04-02 2003-03-31 Solução injetável estável em temperatura ambiente para uso veterinário, e método para produzir a mesma

Country Status (21)

Country Link
US (1) US7879899B2 (pt)
EP (1) EP1494719B1 (pt)
JP (2) JP4689164B2 (pt)
KR (1) KR100884680B1 (pt)
CN (1) CN1265838C (pt)
AU (1) AU2003215771B2 (pt)
BR (1) BR0308874B1 (pt)
CA (1) CA2480065C (pt)
CR (1) CR7515A (pt)
DK (1) DK1494719T5 (pt)
ES (1) ES2659940T3 (pt)
GB (2) GB0207529D0 (pt)
HK (1) HK1077004A1 (pt)
HR (1) HRP20041022B1 (pt)
IL (2) IL164303A0 (pt)
MX (1) MXPA04009407A (pt)
NO (1) NO334122B1 (pt)
NZ (1) NZ535442A (pt)
PL (1) PL218606B1 (pt)
WO (1) WO2003082340A1 (pt)
ZA (1) ZA200408405B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
ES2372499T3 (es) * 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
IL195602A (en) * 2008-11-30 2016-09-29 Orna Levin The arginine-based composition for oral administration
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2675460A4 (en) 2011-02-18 2014-07-09 Kythera Biopharmaceuticals Inc TREATMENT OF FAT TISSUE UNDER CHIN
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
CN102793700B (zh) * 2012-08-29 2014-03-12 郑州后羿制药有限公司 一种含氟甲喹的复方油乳注射液及其制备方法
CN104146951B (zh) * 2014-07-02 2017-01-11 沈阳双鼎制药有限公司 一种右旋布洛芬注射液及其制备方法
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
CN107198676B (zh) * 2017-06-23 2022-04-01 燃点(南京)生物医药科技有限公司 一种供静脉给药用的布洛芬注射液
CN110169951A (zh) * 2019-05-17 2019-08-27 河北远征药业有限公司 一种兽用卡洛芬注射液及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH663788A5 (en) * 1985-02-22 1988-01-15 Hoffmann La Roche New amino acid salts of carprofen - useful as antiinflammatory agents and analgesics
CH673395A5 (pt) * 1987-01-30 1990-03-15 Ciba Geigy Ag
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
SE502225C2 (sv) * 1994-01-12 1995-09-18 Whirlpool Europ Mikrovågsugn
JPH07223942A (ja) * 1994-02-03 1995-08-22 Ildong Pharm Co Ltd プロピオン酸系非ステロイド性薬物を有効成分として含有する新規消炎鎮痛外用ゲル製剤
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
IT1277430B1 (it) 1995-08-03 1997-11-10 Bayer Italia Spa Preparazioni farmaceutiche per uso topico a base di ketoprofene
EP0955063A1 (de) * 1998-04-01 1999-11-10 Basf Aktiengesellschaft Verwendung von wässrigen Zusammensetzungen in subkutanen oder intramuskulär zu verabreichenden Arzneimittel
US20010049363A1 (en) * 1998-05-08 2001-12-06 Warner-Lambert Company Oral composition containing NSAIDs and essential oils
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
SE0100901D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab New composition
ES2189682B1 (es) 2001-12-11 2004-04-01 Laboratorios Del Dr. Esteve, S.A. Preparacion bebible que comprende ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea.

Also Published As

Publication number Publication date
DK1494719T5 (en) 2018-03-12
NO20044723L (no) 2004-11-01
EP1494719A1 (en) 2005-01-12
JP4689164B2 (ja) 2011-05-25
US7879899B2 (en) 2011-02-01
US20050147680A1 (en) 2005-07-07
HRP20041022A2 (en) 2005-02-28
NZ535442A (en) 2007-05-31
CA2480065C (en) 2010-09-28
AU2003215771B2 (en) 2008-08-14
CR7515A (es) 2008-07-29
MXPA04009407A (es) 2005-01-25
DK1494719T3 (en) 2018-03-05
EP1494719B1 (en) 2018-02-14
IL164303A (en) 2008-08-07
ES2659940T3 (es) 2018-03-20
JP2005527561A (ja) 2005-09-15
KR20050002920A (ko) 2005-01-10
HK1077004A1 (en) 2006-02-03
GB2387327A (en) 2003-10-15
NO334122B1 (no) 2013-12-16
GB0307484D0 (en) 2003-05-07
JP2010195823A (ja) 2010-09-09
GB2387327B (en) 2005-01-26
CA2480065A1 (en) 2003-10-09
IL164303A0 (en) 2005-12-18
PL218606B1 (pl) 2015-01-30
CN1646169A (zh) 2005-07-27
WO2003082340B1 (en) 2003-12-24
ZA200408405B (en) 2005-09-28
KR100884680B1 (ko) 2009-02-18
BR0308874B1 (pt) 2014-06-10
GB0207529D0 (en) 2002-05-08
WO2003082340A1 (en) 2003-10-09
AU2003215771A1 (en) 2003-10-13
PL372706A1 (en) 2005-07-25
HRP20041022B1 (en) 2012-09-30
CN1265838C (zh) 2006-07-26

Similar Documents

Publication Publication Date Title
BR0308874A (pt) Composição aquosa injetável, método para produzir a mesma, e, uso de copolìmeros em bloco polioxipropileno/polioxietileno
ATE551988T1 (de) Orale zusammensetzungen, ihre herstellung und verwendung
CY1107617T1 (el) Σκευασμα που αποτελειται απο μεσυλικη (μεθανοσουλφονικη) φαιντολαμινη και η χρηση του
DE69906084T2 (de) Ibuprofen enthaltende schnelllösliche zusammensetzungen mit analgetischer wirkung
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
BR0311261A (pt) Composição lìquida aquosa branqueadora dos dentes, e, método para branquear os dentes
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
CR11037A (es) Derivados de 4-tetrazolil -4fenilpiperidina para tratar el dolor (divisional)
AR027065A1 (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
UY27465A1 (es) Métodos y composiciones para tratar flavivirus y pestivirus con 4' modificaciones nucleosides
CY1107506T1 (el) Μεθοδος για σταθεροποιηση ενωσεων βενζιμιδαζολης
CR11283A (es) "composicion de liberacion sostenida y proceso para producirla"
RS54275B1 (sr) Vodeni 2,6-diizopropilfenol farmaceutski sastavi
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
RS49795B (sr) Sredstva sa antidepresivnim dejstvom
BRPI0410884A (pt) composição de ração para uso em um animal de estimação, e, método para o controle de peso em um animal de estimação
AR025573A1 (es) Composicion laxante
ATE325453T1 (de) Optisch, ausserhalb der maximalen absorption gepumptes yttriumorthovanadat
ATE422169T1 (de) Mit malonsäuresalzen stabilisierte terpenoid- duftkomponenten
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
BRPI0406832A (pt) Método de reduzir o crescimento de pêlos em um ser humano, uso de um conjugado de alfa-difluorometilornitina ou um sal farmaceuticamente aceitável do mesmo, composto, composição, e, uso de um composto
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
NO20002655L (no) 5-(2-imidazolinylamino) -benzimidazol derivater, fremstilling og anvendelse derav som <alfa>-adrenoceptoragonister med forbedret metabolisk stabilitet
AR019119A1 (es) Un metodo para inhibir el ataque fungico y composiciones para utilizar con dicho metodo
BRPI0507802A (pt) composto, composição, e, método para tratar inflamação ou um distúrbio metabólico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 47/10, A61P 29/00, A61P 43/00

Ipc: A61K 47/10 (2011.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/06/2014, OBSERVADAS AS CONDICOES LEGAIS.